Last reviewed · How we verify

NCT07063355

Stripping Massage Technique and Post-isometric Relaxation

Not yet recruiting NA Last updated 14 July 2025
What this trial tests

NA trial testing Stripping Massage Technique: in Trapezius Myalgia in 44 participants. Not yet recruiting.

Timeline
24 July 2025
Primary endpoint
20 September 2025
20 October 2025

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment44
Start date24 July 2025
Primary completion20 September 2025
Estimated completion20 October 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 18 to 50, any sex, with Trapezius Myalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized clinical trial investigates the synergistic effects of stripping massage and Post-Isometric Relaxation (PIR) on pain alleviation, ROM and functional movement improvement in individuals with Trapezius myalgia. A purposive sampling approach will select participants aged 18 and 50 years. A total of 44 patients will be taken, who will be randomly divided into two equal groups, each containing 22 patients. Group A will receive standard baseline management, supplemented with heating pad, active stretching, isometrics and ischemic compression, while Group B will receive the combined management (stripping massage + PIR) .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07063355.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing